Skip to main content
Canna~Fangled Abstracts

Anti-inflammatory potential of delta-9-tetrahydrocannabinol in hyperinsulinemia: an experimental study

By October 14, 2022October 22nd, 2022No Comments


doi: 10.1007/s11033-022-07996-9.

Online ahead of print.
Affiliations 

Abstract

Background: Hyperinsulinemia (HI) means that the amount of insulin in the blood is higher than normal and is often associated with type 2 diabetes. It is known that delta-9-tetrahydrocannabinol (THC) obtained from a medicinal plant, Cannabis sativa, has therapeutic effects on many diseases.

Objective: This study aimed to investigate the effects of THC on inflammatory and oxidant status in rat pancreas with HI.

Methods: Rats were divided into groups; Control, HI, THC and HI + THC. Each group consists of 8 animals. HI and HI + THC groups were given 10% fructose in the drinking water for 12 weeks. In the last four weeks of the experiment, 1.5 mg kg-1 THC was injected intraperitoneally daily into THC and HI + THC groups. The expression of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and nuclear factor-kappa B (NF-κB) were detected. JNK/SAPK and Grap2/p38 levels, total antioxidant and oxidant capacities (TAC and TOC) were analyzed in the pancreas.

Results: Levels of IL-6, NF-κβ, and TNF-α mRNA expression were higher in the pancreas with HI than in the control (p < 0.001 for all). THC treatment reduced the expression of IL-6, NF-κβ, and TNF-α mRNAs in the HI + THC group compared to the HI group (p < 0.001 for all). TOC increased in the HI group compared to the control group (p < 0.001). However, THC treatment reduced TOC levels in the HI + THC group compared to the HI group (p < 0.001).

Conclusion: According to the results, the THC treatment may regulate inflammation and TOC in rats with hyperinsulinemia. Thus, we can say that THC may have anti-inflammatory and antioxidant potential in metabolic disorders.

Keywords: Immunohistochemistry, Inflammation, Oxidative damage, Pancreas, THC

Similar articles

References

    1. Andersen DK, Korc M, Petersen GM et al (2017) Diabetes, pancreatogenic diabetes, and pancreatic cancer. Diabetes 66(5):1103–1110 – PubMed – PMC – DOI
    1. Young BE, Padilla J, Finsen SH et al (2022) Role of endothelin-1 receptors in limiting leg blood flow and glucose uptake during hyperinsulinemia in type 2 diabetes. Endocrinology 163(3):bqac008 – PubMed – DOI
    1. Gupta AP, Syed AA, Garg R et al (2019) Pancreastatin inhibitor PSTi8 attenuates hyperinsulinemia induced obesity and inflammation mediated insulin resistance via MAPK/NOX3-JNK pathway. Eur J Pharmacol 864:172723 – PubMed – DOI
    1. Thomas DD, Corkey BE, Istfan NW et al (2019) Hyperinsulinemia: an early indicator of metabolic dysfunction. J Endocr Soc 3(9):1727–1747 – PubMed – PMC – DOI
    1. Mohamed MA, Ahmed MA, El Sayed RA (2019) Molecular effects of Moringa leaf extract on insulin resistance and reproductive function in hyperinsulinemic male rats. J Diabetes Metab Disord 18(2):487–494 – PubMed – PMC – DOI

LinkOut – more resources


Leave a Reply